During the past decade, CHRU Themba Lethu Clinic conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 2 clinical trials were completed, i.e. on average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "CHRU Themba Lethu Clinic" are "Pulmonary Tuberculosis" (1 trials) and "Tuberculosis" (1 trials). Many other conditions were trialed in "CHRU Themba Lethu Clinic" in a lesser frequency.

Most popular intervention types in "CHRU Themba Lethu Clinic" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Moxifloxacin (M)" (1 trials), "PA-824" (1 trials), "Pretomid (Pa)" (1 trials), "Pyrazinamide (Z)" (1 trials) and "Rifafour" (1 trials). Other intervention names were less common.

The vast majority of trials in "CHRU Themba Lethu Clinic" are 2 trials for "All" genders.

Currently, there are NaN active trials in "CHRU Themba Lethu Clinic". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in CHRU Themba Lethu Clinic, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in CHRU Themba Lethu Clinic, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".